Annexon Inc

NASDAQ:ANNX  
23.92
+1.08 (+4.73%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Annexon Inc Stock, NASDAQ:ANNX

180 Kimball Way, Suite 200, South San Francisco, California 94080
United States of America
Phone: +1.650.822.5500
Number of Employees: 48
http://www.annexonbio.com

Description

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington�s and alzheimer�s disease, multiple sclerosis, glaucoma, parkinson�s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA.